Pharsight

H LUNDBECK patents facing oppositions

Top patents of H LUNDBECK facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3615518B1 15 Dec, 2021 Process for the manufacture of vortioxetine hbr alpha-form NA 1
EP3138564B1 31 Jan, 2018 Nalmefene for reduction of alcohol consumption in specific target populations NA 1
EP2608789B1 12 Apr, 2017 Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine NA 1